Trade Thermo Fisher Scientific - TMO CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.37 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Thermo Fisher Scientific Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 493.04 |
Open* | 494.25 |
1-Year Change* | -11.36% |
Day's Range* | 488.23 - 494.25 |
52 wk Range | 415.60-609.85 |
Average Volume (10 days) | 1.87M |
Average Volume (3 months) | 37.75M |
Market Cap | 186.38B |
P/E Ratio | 31.59 |
Shares Outstanding | 386.37M |
Revenue | 43.42B |
EPS | 15.27 |
Dividend (Yield %) | 0.29022 |
Beta | 0.82 |
Next Earnings Date | Jan 30, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 489.56 | -2.86 | -0.58% | 492.42 | 495.44 | 487.75 |
Dec 7, 2023 | 493.04 | -0.35 | -0.07% | 493.39 | 497.99 | 491.60 |
Dec 6, 2023 | 493.65 | -0.30 | -0.06% | 493.95 | 496.56 | 490.18 |
Dec 5, 2023 | 491.52 | -0.43 | -0.09% | 491.95 | 492.76 | 486.77 |
Dec 4, 2023 | 494.19 | 1.29 | 0.26% | 492.90 | 498.12 | 489.06 |
Dec 1, 2023 | 495.71 | 4.33 | 0.88% | 491.38 | 499.01 | 488.60 |
Nov 30, 2023 | 495.60 | 1.70 | 0.34% | 493.90 | 496.56 | 488.15 |
Nov 29, 2023 | 492.82 | 5.81 | 1.19% | 487.01 | 495.64 | 487.01 |
Nov 28, 2023 | 485.54 | -1.53 | -0.31% | 487.07 | 488.51 | 479.04 |
Nov 27, 2023 | 489.79 | 1.39 | 0.28% | 488.40 | 492.69 | 487.69 |
Nov 24, 2023 | 490.01 | 2.61 | 0.54% | 487.40 | 490.72 | 486.11 |
Nov 22, 2023 | 486.32 | 3.25 | 0.67% | 483.07 | 489.89 | 483.07 |
Nov 21, 2023 | 482.30 | 6.70 | 1.41% | 475.60 | 490.16 | 475.25 |
Nov 20, 2023 | 467.49 | 4.49 | 0.97% | 463.00 | 471.41 | 463.00 |
Nov 17, 2023 | 466.06 | -7.84 | -1.65% | 473.90 | 473.90 | 464.00 |
Nov 16, 2023 | 472.36 | 1.06 | 0.22% | 471.30 | 474.06 | 468.28 |
Nov 15, 2023 | 469.36 | 5.11 | 1.10% | 464.25 | 474.63 | 462.40 |
Nov 14, 2023 | 458.95 | 3.82 | 0.84% | 455.13 | 462.07 | 453.59 |
Nov 13, 2023 | 444.38 | -0.44 | -0.10% | 444.82 | 445.87 | 438.85 |
Nov 10, 2023 | 448.24 | 6.39 | 1.45% | 441.85 | 448.98 | 436.83 |
Thermo Fisher Scientific Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, December 14, 2023 | ||
Time (UTC) 12:00 | Country US
| Event Thermo Fisher Scientific Inc Thermo Fisher Scientific IncForecast -Previous - |
Time (UTC) 12:00 | Country US
| Event Thermo Fisher Scientific Inc Thermo Fisher Scientific IncForecast -Previous - |
Tuesday, January 30, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 Thermo Fisher Scientific Inc Earnings Release Q4 2023 Thermo Fisher Scientific Inc Earnings ReleaseForecast -Previous - |
Wednesday, April 24, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q1 2024 Thermo Fisher Scientific Inc Earnings Release Q1 2024 Thermo Fisher Scientific Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 44915 | 39211 | 32218 | 25542 | 24358 |
Revenue | 44915 | 39211 | 32218 | 25542 | 24358 |
Cost of Revenue, Total | 25944 | 19573 | 16231 | 14213 | 13499 |
Gross Profit | 18971 | 19638 | 15987 | 11329 | 10859 |
Total Operating Expense | 36548 | 29950 | 24424 | 21132 | 20575 |
Selling/General/Admin. Expenses, Total | 8934 | 7816 | 6940 | 6082 | 6028 |
Research & Development | 1471 | 1406 | 1181 | 1003 | 967 |
Unusual Expense (Income) | 140 | 1108 | 89 | -167 | 79 |
Operating Income | 8367 | 9261 | 7794 | 4410 | 3783 |
Interest Income (Expense), Net Non-Operating | -548 | -427 | -569 | -408 | -528 |
Other, Net | 16 | 7 | 68 | 7 | |
Net Income Before Taxes | 7835 | 8841 | 7225 | 4070 | 3262 |
Net Income After Taxes | 7132 | 7732 | 6375 | 3704 | 3055 |
Net Income Before Extra. Items | 6950 | 7725 | 6375 | 3704 | 3055 |
Total Extraordinary Items | 0 | -8 | -117 | ||
Net Income | 6950 | 7725 | 6375 | 3696 | 2938 |
Income Available to Common Excl. Extra. Items | 6950 | 7725 | 6375 | 3704 | 3055 |
Income Available to Common Incl. Extra. Items | 6950 | 7725 | 6375 | 3696 | 2938 |
Diluted Net Income | 6950 | 7725 | 6375 | 3696 | 2938 |
Diluted Weighted Average Shares | 394 | 397 | 399 | 403 | 406 |
Diluted EPS Excluding Extraordinary Items | 17.6396 | 19.4584 | 15.9774 | 9.19107 | 7.52463 |
Dividends per Share - Common Stock Primary Issue | 1.16 | 1 | 0.85 | 0.74 | 0.66 |
Diluted Normalized EPS | 18.0254 | 21.9169 | 16.1875 | 8.85233 | 7.73455 |
Interest Expense (Income) - Net Operating | -17 | 1 | 2 | ||
Other Operating Expenses, Total | 59 | 47 | |||
Minority Interest | -10 | -3 | |||
Equity In Affiliates | -172 | -4 |
Sep 2023 | Jul 2023 | Apr 2023 | Dec 2022 | Oct 2022 | |
---|---|---|---|---|---|
Total revenue | 10574 | 10687 | 10710 | 11450 | 10677 |
Revenue | 10574 | 10687 | 10710 | 11450 | 10677 |
Cost of Revenue, Total | 6145 | 6436 | 6570 | 6844 | 6375 |
Gross Profit | 4429 | 4251 | 4140 | 4606 | 4302 |
Total Operating Expense | 8710 | 9109 | 9147 | 9589 | 8967 |
Selling/General/Admin. Expenses, Total | 1578 | 2145 | 2119 | 2240 | 2208 |
Research & Development | 319 | 345 | 346 | 391 | 351 |
Unusual Expense (Income) | 84 | 183 | 112 | 55 | 33 |
Operating Income | 1864 | 1578 | 1563 | 1861 | 1710 |
Interest Income (Expense), Net Non-Operating | -113 | -148 | -198 | -144 | -118 |
Other, Net | 14 | 0 | -2 | 60 | 9 |
Net Income Before Taxes | 1765 | 1430 | 1363 | 1777 | 1601 |
Net Income After Taxes | 1712 | 1378 | 1317 | 1604 | 1570 |
Net Income Before Extra. Items | 1715 | 1361 | 1289 | 1576 | 1495 |
Net Income | 1715 | 1361 | 1289 | 1576 | 1495 |
Income Available to Common Excl. Extra. Items | 1715 | 1361 | 1289 | 1576 | 1495 |
Income Available to Common Incl. Extra. Items | 1715 | 1361 | 1289 | 1576 | 1495 |
Diluted Net Income | 1715 | 1361 | 1289 | 1576 | 1495 |
Diluted Weighted Average Shares | 388 | 388 | 388 | 392 | 395 |
Diluted EPS Excluding Extraordinary Items | 4.4201 | 3.50773 | 3.32216 | 4.02041 | 3.78481 |
Dividends per Share - Common Stock Primary Issue | 0.35 | 0.35 | 0.3 | 0.3 | 0.3 |
Diluted Normalized EPS | 4.6176 | 3.9672 | 3.67828 | 4.15857 | 3.92135 |
Other Operating Expenses, Total | 59 | ||||
Minority Interest | 20 | -1 | -3 | 2 | -3 |
Equity In Affiliates | -17 | -16 | -25 | -30 | -72 |
Depreciation / Amortization | 584 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 25229 | 20113 | 21957 | 11893 | 10625 |
Cash and Short Term Investments | 8526 | 4477 | 10353 | 2436 | 2134 |
Cash & Equivalents | 8524 | 4477 | 10325 | 2399 | 2103 |
Short Term Investments | 2 | 28 | 37 | 31 | |
Total Receivables, Net | 9427 | 8945 | 6472 | 4952 | 4136 |
Accounts Receivable - Trade, Net | 9427 | 8945 | 6472 | 4952 | 4136 |
Total Inventory | 5634 | 5051 | 4029 | 3370 | 3005 |
Other Current Assets, Total | 1642 | 1640 | 1103 | 1135 | 1350 |
Total Assets | 97154 | 95123 | 69052 | 58381 | 56232 |
Property/Plant/Equipment, Total - Net | 10873 | 9864 | 6687 | 5448 | 4165 |
Property/Plant/Equipment, Total - Gross | 15862 | 14124 | 10352 | 8463 | 6820 |
Accumulated Depreciation, Total | -4989 | -4260 | -3665 | -3015 | -2655 |
Goodwill, Net | 41196 | 41924 | 26041 | 25714 | 25347 |
Intangibles, Net | 17442 | 20113 | 12685 | 14014 | 14978 |
Other Long Term Assets, Total | 2352 | 3087 | 1682 | 1312 | 1117 |
Total Current Liabilities | 17010 | 13436 | 10304 | 6197 | 6147 |
Accounts Payable | 3381 | 2867 | 2175 | 1920 | 1615 |
Accrued Expenses | 5433 | 5377 | 4098 | 2674 | 2436 |
Notes Payable/Short Term Debt | 310 | 2522 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 5269 | 15 | 2628 | 676 | 1271 |
Other Current Liabilities, Total | 2617 | 2655 | 1403 | 927 | 825 |
Total Liabilities | 53176 | 54330 | 34545 | 28706 | 28646 |
Total Long Term Debt | 28909 | 32333 | 19107 | 17076 | 17719 |
Long Term Debt | 28909 | 32333 | 19107 | 17076 | 17719 |
Deferred Income Tax | 2849 | 3837 | 1794 | 2192 | 2265 |
Other Liabilities, Total | 4238 | 4540 | 3340 | 3241 | 2515 |
Total Equity | 43978 | 40793 | 34507 | 29675 | 27586 |
Common Stock | 441 | 439 | 437 | 434 | 432 |
Additional Paid-In Capital | 16743 | 16174 | 15579 | 15064 | 14621 |
Retained Earnings (Accumulated Deficit) | 41910 | 35431 | 28116 | 22092 | 18696 |
Treasury Stock - Common | -12017 | -8922 | -6818 | -5236 | -3665 |
Unrealized Gain (Loss) | -33 | -35 | -91 | -71 | -52 |
Other Equity, Total | -3066 | -2294 | -2716 | -2608 | -2446 |
Total Liabilities & Shareholders’ Equity | 97154 | 95123 | 69052 | 58381 | 56232 |
Total Common Shares Outstanding | 390.511 | 394.435 | 396.671 | 398.74 | 402.122 |
Long Term Investments | 55 | 22 | |||
Minority Interest | 170 | 184 | |||
Note Receivable - Long Term | 7 |
Sep 2023 | Jul 2023 | Apr 2023 | Dec 2022 | Oct 2022 | |
---|---|---|---|---|---|
Total Current Assets | 23092 | 19995 | 20209 | 25229 | 19299 |
Cash and Short Term Investments | 6151 | 3133 | 3482 | 8526 | 2941 |
Cash & Equivalents | 6151 | 3133 | 3482 | 8524 | 2919 |
Short Term Investments | 2 | 22 | |||
Total Receivables, Net | 9835 | 9486 | 9297 | 9427 | 8919 |
Accounts Receivable - Trade, Net | 9835 | 9486 | 9297 | 9427 | 8919 |
Total Inventory | 5404 | 5655 | 5664 | 5634 | 5722 |
Other Current Assets, Total | 1702 | 1721 | 1766 | 1642 | 1717 |
Total Assets | 97057 | 94105 | 94658 | 97154 | 90536 |
Property/Plant/Equipment, Total - Net | 9167 | 9292 | 9354 | 9280 | 8628 |
Goodwill, Net | 43583 | 43273 | 43140 | 41196 | 40488 |
Intangibles, Net | 17091 | 17437 | 17972 | 17442 | 17813 |
Other Long Term Assets, Total | 4119 | 4102 | 3975 | 4000 | 4299 |
Total Current Liabilities | 14158 | 14112 | 15884 | 17010 | 11118 |
Accounts Payable | 2508 | 2423 | 2798 | 3381 | 2471 |
Accrued Expenses | 4308 | 4285 | 4302 | 5433 | 5068 |
Notes Payable/Short Term Debt | 0 | 500 | 824 | 310 | 0 |
Current Port. of LT Debt/Capital Leases | 4795 | 4314 | 5298 | 5269 | 1010 |
Other Current Liabilities, Total | 2547 | 2590 | 2662 | 2617 | 2569 |
Total Liabilities | 51729 | 50353 | 52401 | 53176 | 46987 |
Total Long Term Debt | 30489 | 29194 | 29135 | 28909 | 28150 |
Long Term Debt | 30489 | 29194 | 29135 | 28909 | 28150 |
Deferred Income Tax | 2620 | 2842 | 2976 | 2849 | 3140 |
Other Liabilities, Total | 4326 | 4042 | 4230 | 4238 | 4401 |
Total Equity | 45328 | 43752 | 42257 | 43978 | 43549 |
Common Stock | 442 | 441 | 441 | 441 | 440 |
Additional Paid-In Capital | 17165 | 17030 | 16889 | 16743 | 16596 |
Retained Earnings (Accumulated Deficit) | 45869 | 44289 | 43064 | 41910 | 40452 |
Treasury Stock - Common | -15121 | -15084 | -15083 | -12017 | -11011 |
Unrealized Gain (Loss) | -28 | -29 | -30 | -33 | -33 |
Other Equity, Total | -2999 | -2895 | -3024 | -3066 | -2895 |
Total Liabilities & Shareholders’ Equity | 97057 | 94105 | 94658 | 97154 | 90536 |
Total Common Shares Outstanding | 386.372 | 385.95 | 385.721 | 390.511 | 392.196 |
Property/Plant/Equipment, Total - Gross | |||||
Accumulated Depreciation, Total | |||||
Minority Interest | 136 | 163 | 176 | 170 | 178 |
Note Receivable - Long Term | 5 | 6 | 8 | 7 | 9 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 6960 | 7728 | 6375 | 3696 | 2938 |
Cash From Operating Activities | 9154 | 9312 | 8289 | 4973 | 4543 |
Cash From Operating Activities | 986 | 831 | 658 | 564 | 2267 |
Deferred Taxes | -995 | -647 | -552 | -302 | -379 |
Non-Cash Items | 857 | 1187 | 536 | -33 | 287 |
Changes in Working Capital | -1049 | -1548 | -395 | -665 | -570 |
Cash From Investing Activities | -2159 | -21932 | -1510 | -1487 | -1253 |
Capital Expenditures | -2243 | -2523 | -1474 | -926 | -758 |
Other Investing Cash Flow Items, Total | 84 | -19409 | -36 | -561 | -495 |
Cash From Financing Activities | -2810 | 6581 | 959 | -3118 | -2237 |
Financing Cash Flow Items | -9 | -91 | -147 | -69 | -51 |
Total Cash Dividends Paid | -455 | -395 | -337 | -297 | -266 |
Issuance (Retirement) of Stock, Net | -3000 | -1844 | -1304 | -1347 | -364 |
Issuance (Retirement) of Debt, Net | 654 | 8911 | 2747 | -1405 | -1556 |
Foreign Exchange Effects | -139 | 194 | 176 | -63 | -297 |
Net Change in Cash | 4046 | -5845 | 7914 | 305 | 756 |
Cash Taxes Paid | 1234 | 2182 | 1324 | 896 | 591 |
Cash Interest Paid | 667 | 555 | 471 | 790 | 687 |
Amortization | 2395 | 1761 | 1667 | 1713 |
Apr 2023 | Dec 2022 | Oct 2022 | Jul 2022 | Apr 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1292 | 6960 | 5386 | 3888 | 2220 |
Cash From Operating Activities | 729 | 9154 | 5667 | 3730 | 2202 |
Cash From Operating Activities | 253 | 986 | 730 | 486 | 250 |
Amortization | 606 | 2395 | 1803 | 1209 | 609 |
Deferred Taxes | -146 | -995 | -862 | -601 | -339 |
Non-Cash Items | 257 | 857 | 701 | 472 | 337 |
Changes in Working Capital | -1533 | -1049 | -2091 | -1724 | -875 |
Cash From Investing Activities | -3142 | -2159 | -1634 | -1089 | -670 |
Capital Expenditures | -458 | -2243 | -1693 | -1146 | -640 |
Other Investing Cash Flow Items, Total | -2684 | 84 | 59 | 57 | -30 |
Cash From Financing Activities | -2593 | -2810 | -5201 | -5050 | -3145 |
Financing Cash Flow Items | 20 | -9 | -86 | -48 | -36 |
Total Cash Dividends Paid | -117 | -455 | -338 | -220 | -103 |
Issuance (Retirement) of Stock, Net | -3000 | -3000 | -1943 | -1949 | -1998 |
Issuance (Retirement) of Debt, Net | 504 | 654 | -2834 | -2833 | -1008 |
Foreign Exchange Effects | -31 | -139 | -389 | -177 | -99 |
Net Change in Cash | -5037 | 4046 | -1557 | -2586 | -1712 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.3978 | 32411301 | 3067 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.7696 | 18408301 | -388612 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.1759 | 16116956 | 55458 | 2023-06-30 | LOW |
Capital World Investors | Investment Advisor | 3.3362 | 12876098 | -48366 | 2023-06-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.2469 | 8672091 | -2077992 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.2212 | 8572754 | 547312 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8082 | 6978869 | -6715 | 2023-06-30 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.6887 | 6517361 | -1270699 | 2023-06-30 | LOW |
Capital Research Global Investors | Investment Advisor | 1.5783 | 6091325 | 157512 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4612 | 5639611 | 219567 | 2022-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 1.1087 | 4278887 | 209573 | 2023-06-30 | LOW |
Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 1.0313 | 3980403 | 378915 | 2023-06-30 | LOW |
TCI Fund Management Limited | Hedge Fund | 0.8222 | 3173182 | 2339032 | 2023-06-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.8035 | 3100948 | -193634 | 2023-06-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.7975 | 3078107 | -486002 | 2023-06-30 | |
JP Morgan Asset Management | Investment Advisor | 0.7742 | 2987984 | -243076 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.7271 | 2806223 | -83893 | 2023-06-30 | LOW |
BofA Global Research (US) | Research Firm | 0.7041 | 2717630 | -367618 | 2023-06-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.6763 | 2610108 | 50802 | 2023-06-30 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.6678 | 2577185 | -145338 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Thermo Fisher Company profile
Thermo Fisher Scientific Inc. (TMO) is a supplier of scientific laboratory products, instruments, software and other tools. The company was formed in a tax-free stock-for-stock merger of Thermo Electron Corporation with Fisher Scientific International Inc. in 2006.
The company provides services through various brands including Thermo Fishers, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Thermo Fisher works on accelerating life sciences research by solving complex analytical challenges. Its products aim to increase productivity in laboratories and improve patient health through diagnostics and therapy development.
The four segments that Thermo Fisher Scientific caters to are industrial and applied research, diagnostics and healthcare, academic and government research, and pharmaceuticals and biotechnology.
As of June 2022, Thermo Fisher has developed Orbitrap Exploris MX mass spectrometer, cell therapy workflow solutions, Oncomine Dx Target Test and several other solutions that aim to make the diagnosis of infections and diseases easier and enable production of drugs and vaccines.
Thermo Fisher Scientific Inc. stock is trading on the New York Stock Exchange (NYSE) under the ticker symbol TMO. You can follow live TMO stock movement and price history, and stay on top of the latest TMO share value at Capital.com.
Industry: | Advanced Medical Equipment & Technology (NEC) |
168 Third Avenue
WALTHAM
MASSACHUSETTS 02451
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com